united states of america
15 Jan 2026 06:00
Santhera Receives Swissmedic Approval of AGAMREE® (Vamorolone) for the Treatment of Duchenne Muscular Dystrophy (benzinga)
Commercial launch in Switzerland anticipated in H2 2026Pratteln, Switzerland, January 15, 2026 – San...